Mark Wiggins
Corporate Officer/Principal at VAXCYTE, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Susan Alexander | F | 67 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 21 years |
| Andrew Guggenhime | M | 55 | 4 years | |
| Grant Pickering | M | 56 | 11 years | |
| Mikhail Eydelman | M | 43 | 2 years | |
| Andreas Klostermann | M | - |
selectION, Inc.
 selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | - |
| Iris Löw-Friedrich | M | 63 | 2 years | |
| Teri Loxam | F | 52 | 3 years | |
| Janet Graesser | F | - | 3 years | |
| Carlos Paya | M | 65 | 3 years | |
| Halley Gilbert | F | 54 | 4 years | |
| Jeff Fairman | M | 60 | 11 years | |
| Carol Lam | F | 64 | 3 years | |
| Lisa Johnson-Pratt | M | 60 | 3 years | |
| K. Hirth | M | 72 | 8 years | |
| Heath Lukatch | M | 56 | 6 years | |
| Antonius P. Schuh | M | 59 |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | - |
| Jacks Lee | M | 60 | 1 years | |
| Anne Drapeau | F | 57 | 3 years | |
| Saundra Pelletier | F | 54 | 4 years | |
| Elvia Cowan | F | 51 | 2 years | |
| Donald Scifres | M | - |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | - |
| Cam Gallagher | M | 54 |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | 6 years |
| James Wassil | M | 54 | 5 years | |
| Whitney Jones | F | - | - | |
| Michael Dambach | M | 57 | 17 years | |
| Harpreet Dhaliwal | M | - | 3 years | |
| Paul Sauer | M | 63 | 8 years | |
| Brenda Marczi | F | - | 3 years | |
| James L. Freddo | M | 69 | 4 years | |
| Jakub Simon | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Craig Eric Schneier | M | 76 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 8 years |
| James B. Wyngaarden | M | 99 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 23 years |
| Michael Patrick Smith | M | 55 | - | |
| James Tobin | M | 79 | 5 years | |
| Martin R. Brown | M | - |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | - |
| Paul Clancy | M | 62 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 16 years |
| Robert A. Hamm | M | 72 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 7 years |
| Cecil B. Pickett | M | 78 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB)
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 13 years |
| Ann Rhoads | F | 58 | 7 years | |
| Stelios Papadopoulos | M | 75 | 15 years | |
| William Young | M | 79 | 11 years | |
| William Rastetter | M | 75 | 19 years | |
| James Breitmeyer | M | 70 | 16 years | |
| Roger L. Hawley | M | 71 | 13 years | |
| C. Hartley | M | 81 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 17 years |
| Renee Tannenbaum | M | 72 | 7 years | |
| Jim Suddendorf | M | - |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 12 years |
| Mary E. Stutts | F | 68 | 2 years | |
| Hugh A. D'Andrade | M | 85 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 4 years |
| Eric S. Hoffman | M | 54 | 5 years | |
| Vickie Reed | F | 62 | - | |
| Michael MacLean | M | 58 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 4 years |
| Erle T. Mast | M | 61 | 14 years | |
| Edward F. Smith | M | 70 | 9 years | |
| Arda Minocherhomjee | M | 70 | 4 years | |
| Ted Wang | M | 57 | 1 years | |
| John Cox | M | 61 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 14 years |
| Arnold R. Gammaitoni | M | 56 | 10 years | |
| Steven A. Johnson | M | - | 11 years | |
| Patricia Bitar | F | 65 | 4 years | |
| Samantha Truex | F | - | 8 years | |
| Youssef El Zein | M | 75 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 25 years |
| Shawnte Mitchell | F | 46 | - | |
| Lynne Sullivan | F | 58 | 10 years | |
| Ashish M. Sagrolikar | M | 57 | 4 years | |
| Denelle Waynick | F | 57 | 2 years | |
| Caroline Loewy | F | 58 | 2 years | |
| Thomas F. Keller | M | 92 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 11 years |
| Lawrence C. Best | M | 75 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 5 years |
| Raul Cesan | M | 76 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 7 years |
| Michael Kamarck | M | 73 | 2 years | |
| James Blair | M | 84 | 8 years | |
| Mary L. Good | M | 93 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 10 years |
| James Mullen | M | 65 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 19 years |
| Burt Adelman | M | 71 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 17 years |
| Daniel E. Greenleaf | M | 59 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 10 years |
| Joseph Mara | M | 49 | - | |
| Louis C. Bock | M | 59 | 16 years | |
| Paul C. Zamecnik | M | - |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
| John Dunn | M | 72 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 10 years |
| Brian Posner | M | 62 | 14 years | |
| Kurt C. Wheeler | M | 71 | 7 years | |
| Michael Kelly | M | 67 | 2 years | |
| Nancy L. Leaming | F | 76 | 14 years | |
| Sylvie Grégoire | M | 62 | 8 years | |
| Peter Kellogg | M | 67 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 7 years |
| Connie Matsui | F | 70 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 18 years |
| Gilmore O’Neill | M | 59 | 15 years | |
| Lisa Amaya Price | F | - | 8 years | |
| James Basta | M | 58 | - | |
| Paula Cobb | F | 51 | 13 years | |
| Jennifer A. Spinella | F | - | - | |
| Carlo Tanzi | M | - | 8 years | |
| Esther Alegria | M | 66 | 10 years | |
| Andrew R. de Guttadauro | M | 57 | - | |
| Christine Anna White | M | 72 | 9 years | |
| Elan Ezickson | M | 60 | 9 years | |
| Nicolas Barthelemy | M | 58 | 8 years | |
| Bethany Sensenig | F | 48 | 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Wiggins
- Personal Network
